Vzarii Therapeutics
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Vzarii Therapeutics
Loretto Callaghan Cdir
CEO & Co-Founder
About Vzarii Therapeutics
Vzarii is a preclinical stage biotech company formed on pioneering research from Trinity College Dublin. Our focus is on addressing mitochondrial dysfunction which is implicated in the pathophysiology of many neurodegenerative diseases.
$
Vzarii Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Vzarii Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Vzarii Therapeutics has never raised funding before.
United States
United Kingdom
Sweden
BelgiumFrequently asked questions
Vzarii Therapeutics is located in XX.
Vzarii Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
